Analyst Ratings for InVivo Therapeutics (NVIV)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
7/31/2017 | Raymond James | N/A | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
2.45 (0.32) |
-86.94% | Details |
7/21/2016 | Ladenburg Thalmann | N/A | New Coverage | Buy (N/A) |
23.25 (N/A) |
6.48 (0.32) |
-95.06% | Details |